Stone Run Capital, LLC Becton Dickinson & CO Transaction History

Stone Run Capital, LLC

  • $250 Billion
  • Q2 2024

A detailed history of Stone Run Capital, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Stone Run Capital, LLC holds 27,742 shares of BDX stock, worth $6.53 Million. This represents 2.59% of its overall portfolio holdings.

Number of Shares
27,742
Previous 26,591 4.33%
Holding current value
$6.53 Million
Previous $6.58 Billion 1.46%
% of portfolio
2.59%
Previous 2.51%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$225.07 - $246.17 $259,055 - $283,341
1,151 Added 4.33%
27,742 $6.48 Billion
Q1 2024

May 14, 2024
SELL
$233.45 - $247.73 $1.4 Million - $1.49 Million
-5,999 Reduced 18.41%
26,591 $6.58 Billion
Q4 2023

Feb 14, 2024
BUY
$232.24 - $267.23 $2.01 Million - $2.31 Million
8,640 Added 36.08%
32,590 $7.95 Billion
Q3 2023

Nov 14, 2023
BUY
$254.9 - $283.59 $6.1 Million - $6.79 Million
23,950 New
23,950 $6.19 Billion
Q2 2023

Aug 14, 2023
BUY
$238.39 - $265.32 $2.1 Million - $2.33 Million
8,790 Added 37.28%
32,370 $8.55 Million
Q1 2023

May 15, 2023
SELL
$229.71 - $259.35 $801,687 - $905,131
-3,490 Reduced 12.89%
23,580 $5.84 Million
Q4 2022

Feb 14, 2023
BUY
$218.29 - $256.91 $523,677 - $616,327
2,399 Added 9.72%
27,070 $6.89 Million
Q3 2022

Nov 14, 2022
SELL
$51.03 - $264.23 $10,154 - $52,581
-199 Reduced 0.8%
24,671 $5.5 Million
Q2 2022

Aug 15, 2022
SELL
$234.74 - $275.42 $2.07 Million - $2.43 Million
-8,815 Reduced 26.17%
24,870 $6.13 Million
Q1 2022

May 16, 2022
BUY
$243.64 - $270.48 $816,437 - $906,378
3,351 Added 11.05%
33,685 $8.96 Million
Q4 2021

Feb 14, 2022
BUY
$230.08 - $250.94 $276,326 - $301,378
1,201 Added 4.12%
30,334 $7.63 Million
Q3 2021

Nov 15, 2021
SELL
$232.72 - $256.47 $1.31 Million - $1.44 Million
-5,632 Reduced 16.2%
29,133 $7.16 Million
Q2 2021

Aug 16, 2021
SELL
$232.65 - $254.58 $697,717 - $763,485
-2,999 Reduced 7.94%
34,765 $8.45 Million
Q1 2021

May 17, 2021
SELL
$232.09 - $256.88 $51,059 - $56,513
-220 Reduced 0.58%
37,764 $9.18 Million
Q4 2020

Feb 16, 2021
BUY
$221.92 - $245.94 $1.61 Million - $1.78 Million
7,250 Added 23.59%
37,984 $9.51 Million
Q3 2020

Nov 13, 2020
BUY
$215.77 - $276.76 $278,559 - $357,297
1,291 Added 4.38%
30,734 $7.15 Million
Q2 2020

Aug 14, 2020
SELL
$219.9 - $263.41 $873,882 - $1.05 Million
-3,974 Reduced 11.89%
29,443 $7.04 Million
Q1 2020

May 15, 2020
BUY
$195.69 - $279.01 $53,423 - $76,169
273 Added 0.82%
33,417 $7.68 Million
Q4 2019

Feb 14, 2020
BUY
$236.45 - $266.82 $589,942 - $665,715
2,495 Added 8.14%
33,144 $9.01 Million
Q3 2019

Nov 14, 2019
BUY
$230.58 - $256.08 $86,698 - $96,286
376 Added 1.24%
30,649 $7.75 Million
Q2 2019

Aug 14, 2019
SELL
$217.4 - $246.08 $296,751 - $335,899
-1,365 Reduced 4.31%
30,273 $7.63 Million
Q1 2019

May 14, 2019
BUY
$206.05 - $248.17 $463,818 - $558,630
2,251 Added 7.66%
31,638 $7.9 Million
Q4 2018

Feb 14, 2019
SELL
$204.73 - $257.93 $1.81 Million - $2.28 Million
-8,852 Reduced 23.15%
29,387 $6.62 Million
Q3 2018

Nov 14, 2018
SELL
$233.07 - $256.0 $5,826 - $6,400
-25 Reduced 0.07%
38,239 $9.98 Million
Q2 2018

Aug 14, 2018
SELL
$208.1 - $233.85 $790,571 - $888,396
-3,799 Reduced 9.03%
38,264 $9.17 Million
Q1 2018

May 14, 2018
BUY
$205.46 - $240.27 $889,641 - $1.04 Million
4,330 Added 11.48%
42,063 $9.12 Million
Q4 2017

Feb 15, 2018
BUY
$189.0 - $222.64 $1.24 Million - $1.46 Million
6,553 Added 21.02%
37,733 $8.08 Million
Q3 2017

Nov 14, 2017
BUY
$186.89 - $198.9 $5.83 Million - $6.2 Million
31,180
31,180 $6.11 Million

Others Institutions Holding BDX

# of Institutions
1,736
Shares Held
253M
Call Options Held
586K
Put Options Held
656K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $67.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Stone Run Capital, LLC Portfolio

Follow Stone Run Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Run Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email